TrialDrugs in R&D2023

Hepatotoxicity of AKR1C3 Inhibitor BAY1128688: Findings from an Early Terminated Phase IIa Trial for the Treatment of Endometriosis.

Jan Hilpert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.